Several other research analysts also recently commented on the stock. Canaccord Genuity Group cut their price objective on shares of Cybin from $86.00 to $73.00 and set a “buy” rating for the ...

Guggenheim has initiated its coverage of psychedelic drug developer Cybin (NYSE:CYBN ... wrote as he projected further upside for the stock given a mid-stage readout expected for CYBN’s anxiety ...

BCLI Brainstorm Cell Therapeutics Inc.

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Find Spa Salon Owner stock video, 4K footage, and other HD footage from iStock. Get higher quality Spa Salon Owner content, for less—All of our 4K video clips are the same price as HD. Video Back ...

Western Midstream Partners L.P. 4.34% $13.34B ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...